Worldwide Embalmer White Fibrous Clot Survey: Why It Matters, By Brian Simpson
The issue of unusual blood clots, particularly white fibrous clots, has gained attention following the rollout of Covid-19 vaccines, as highlighted by Retired U.S. Air Force Major Thomas Haviland's global surveys. These investigations, summarised in a May 17, 2025, article by Nicolas Hulscher, MPH, include the 2024 Worldwide Embalmer White Fibrous Clot Survey and the 2024 People's Blood Clot Survey. Below is an account of the blood clot issue. Why care about it? Because these clots may well be inside a Covid mRNA vaxxed person. As well, I will put this discussion in note form as there are technical points that the reader can skip but still see the general gist.
1. Worldwide Embalmer White Fibrous Clot SurveyScope: The survey collected responses from 301 embalmers across multiple countries in 2024, building on prior years' data.
Key Findings:
Prevalence: 83% of embalmers (250 respondents) reported observing large, white, fibrous clots in corpses during 2024, up from 73% in 2023. These clots appeared in approximately 27.5% of embalmed bodies, compared to 20% the previous year.
Novelty: Embalmers noted these clots were not seen before 2021, coinciding with the introduction of Covid-19 vaccines.
Microclotting: 78% of embalmers reported "microclotting" (described as "dirty blood" or "coffee grounds") in about 22% of cases, a significant increase from less than 5% pre-2020.
Lack of Institutional Response: Most embalmers said their professional associations have not addressed these anomalies, despite their high visibility in the field.
Significance: The survey suggests a correlation between the emergence of these clots and the Covid-19 vaccination campaign, as embalmers consistently reported these structures only after 2021.
2. People's Blood Clot SurveyScope: This survey gathered 1,425 self-reported or observed clotting cases from individuals across 40 countries, focusing on clotting events since 2020.
Key Findings:
Vaccination Link: 91% (1,294 respondents) with clotting issues had received at least one Covid-19 vaccine dose.
Temporal Trends: Only 79 clotting cases were reported in 2020 (pre-vaccine), while over 500 cases per year were reported from 2021 to 2024.
Delayed Onset: 26% of clotting cases occurred six months to over a year after vaccination, suggesting potential delayed-onset complications.
Clot Locations: The most common sites were legs, lungs, brain, and heart, aligning with clot locations reported in the CDC's V-safe data.
Severity: 257 individuals required surgical clot removal, and 242 died from clot-related complications.
Significance: The survey indicates a sharp rise in clotting events post-vaccination, with severe outcomes in a notable subset of cases.
3. Characteristics of the ClotsComposition: Analysis by Greg Harrison's team and Dr. Kevin McCairn found that these clots are not typical blood thrombi but are composed of:
Misfolded proteins (amyloids).
Abnormal fibrinogen ratios and high phosphorus levels.
Positive for prion seeding (via RT-QuIC testing), raising concerns about infectious protein activity.
Distinction: These white fibrous clots differ from standard blood clots in structure and composition, suggesting a unique pathological process.
4. Broader Context and ChallengesInstitutional Silence:
Haviland submitted findings annually to the FDA, CDC, and NIH, but received no response.
Funeral director associations in the UK and elsewhere have declined to investigate, despite ethical obligations to address unusual post-mortem findings.
Vascular surgeons and and lab workers reportedly observe similar clots in living patients but remain silent, often citing fear of professional repercussions.
Suppression Concerns: The lack of institutional engagement has led independent researchers and embalmers to document the issue, framing it as an urgent, under-investigated medical phenomenon.
Ongoing Efforts: Haviland is set to present his findings to the Tennessee Funeral Directors Association in June 2025, aiming to raise awareness within the field.
5. ImplicationsPublic Health: The surveys suggest a potential link between Covid-19 vaccines and abnormal clotting, with significant morbidity (surgical interventions) and mortality (242 deaths in the People's Survey).
Scientific Questions: The amyloid composition and prion-like properties of the clots raise concerns about novel pathological mechanisms, possibly related to vaccine-induced protein misfolding or other delayed effects.
Call for Investigation: The data underscores the need for rigorous, transparent studies to confirm the prevalence, cause, and mechanisms of these clots, as well as to assess their public health impact.
Critical PointsCorrelation vs. Causation: While the surveys note a temporal association between Covid-19 vaccination and clot formation, they do not establish causation. Other factors (e.g., Covid-19 infection, changes in embalming practices, or reporting biases) could contribute, so this needs scientific investigation.
In summary, Haviland's surveys document a striking increase in unusual white fibrous clots and microclotting since the Covid-19 vaccine rollout, reported by embalmers and individuals globally. These findings, coupled with the clots' unique amyloid composition and severe outcomes in some cases, highlight a potentially significant post-vaccine pathology that remains under-investigated by major health authorities. Further research is critical to clarify the scope and cause of this issue. A hidden bio-time bomb may be inside the Covid vaxxed.
https://www.thefocalpoints.com/p/worldwide-embalmer-survey-reveals
"Worldwide Embalmer Survey Reveals Striking Rise in White Fibrous Clots Following COVID-19 VaccinationUSAF Ret. Major Thomas Haviland's global survey finds 83% of embalmers now report white fibrous clots—found in roughly 27.5% of bodies since mass COVID-19 vaccination began.
Retired U.S. Air Force Major Thomas Haviland joined epidemiologist Nicolas Hulscher to present findings from two large-scale investigations into post-vaccine clotting abnormalities—one focused on the deceased, the other on the living.
The latest Worldwide Embalmer White Fibrous Clot Survey—a multi-year investigation documenting the sudden and widespread appearance of anomalous white fibrous clots in the deceased—draws from the testimony of embalmers around the globe who began observing these structures after the rollout of COVID-19 mRNA injections.
The companion People's Blood Clot Survey gathers more than 1,400 self-reported and observed clotting cases from individuals across 40 countries, offering further insight into delayed clotting complications following vaccination.
2024 Worldwide Embalmer Blood Clot SurveyRespondents: 301 embalmers from multiple countries
Key Results:
83% (250 embalmers) reported seeing large, white, fibrous clots in corpses during 2024—up from 73% in 2023.
These clots were found in an average of 27.5% of all embalmed bodies, a rise from 20% in the previous year.
Embalmers stated they had never observed these clots before 2021, coinciding with the introduction of COVID-19 vaccines.
78% also reported seeing signs of microclotting—described as "dirty blood" or "coffee grounds"—in about 22% of cases, compared to less than 5% before 2020.
Most embalmers acknowledged that their professional associations have never addressed this issue, despite high visibility in the field.
2024 People's Blood Clot SurveyRespondents: 1,425 individuals from over 40 countries
Purpose: To gather self-reported or observed blood clotting events since 2020
Key Results:
1,294 individuals (91%) with clotting issues had received at least one COVID-19 vaccine dose.
Only 79 clotting cases were reported in 2020 (pre-vaccine), compared to over 500 per year in 2021–2024.
26% of clotting cases occurred six months to over a year after injection—supporting theories of delayed-onset clot development.
Most common clot locations: legs, lungs, brain, and heart—exactly matching CDC's V-safe "free text" field analysis.
257 individuals required surgical removal of clots; 242 individuals died from clot-related complications.
Broader Implications & SuppressionMajor Haviland submitted his survey findings each year to the FDA, CDC, and NIH—without any response.
Associations in the UK and other nations refused to participate despite having codes of ethics requiring investigation of unusual post-mortem findings.
Vascular surgeons and cath lab workers, though reportedly encountering similar clots in living patients, have remained silent—many citing fear of professional repercussions.
Analysis by Greg Harrison's team and Dr. Kevin McCairn revealed that these clots:
Are composed of misfolded proteins (amyloids)—not blood.
Contain abnormal fibrinogen ratios and high phosphorus, not typical of thrombi.
Tested positive for prion seeding using RT-QuIC, raising concerns of infectious protein activity.
As Tom Haviland prepares to present to the Tennessee Funeral Directors Association in June 2025, the data continues to point to a persistent, under-investigated, and potentially catastrophic post-vaccine pathology. Despite the reluctance of institutional authorities to act, independent researchers and embalmers worldwide are stepping up to document what many believe is one of the most urgent and unaddressed medical phenomena of our time."
Comments